Anti-neoplastic glucuronide prodrug treatment of human tumor cells targeted with a monoclonal antibody-enzyme conjugate
- 24 October 1991
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (10) , 2062-2065
- https://doi.org/10.1016/0006-2952(91)90612-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- A cytotoxic agent can be generated selectively at cancer sitesBritish Journal of Cancer, 1988
- Antibody directed enzymes revive anti-cancer prodrugs conceptBritish Journal of Cancer, 1987
- Measurement of protein using bicinchoninic acidAnalytical Biochemistry, 1985
- Preparation of F(ab′)2 fragments from mouse IgG of various subclassesJournal of Immunological Methods, 1983
- Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagentBiochemical Journal, 1978
- Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell β‐glucuronidase activityCancer, 1976
- Metabolism of aniline mustard [N,N-di-(2-Chloroethyl)-aniline]Biochemical Pharmacology, 1973
- Aryl-2-halogenoalkylamines—XXVI glucuronic, sulphuric and phosphoric esters of
di -2-chloroethylaminophenol Biochemical Pharmacology, 1972 - Cure of Mice bearing Advanced Plasma Cell Tumours with Aniline Mustard : the Relationship between Glucuronidase Activity and Tumour SensitivityNature, 1966
- Cure of Mice Bearing Advanced Plasma Cell Tumours With Aniline MustardNature, 1965